Caitong International Asset Management’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.58K Sell
363
-1,403
-79% -$23.4K ﹤0.01% 1134
2025
Q4
$31.9K Buy
+1,766
New +$30.4K 0.01% 869
2025
Q3
Sell
-510
Closed -$5.55K 2285
2025
Q2
$5.55K Buy
510
+239
+88% +$2.68K ﹤0.01% 978
2025
Q1
$3.38K Buy
+271
New +$4.46K ﹤0.01% 1140

Other funds holding MESO

Caitong International Asset Management's MESO Position: Q1 2026 in Review

Caitong International Asset Management reduced its Mesoblast (MESO) stake by 79% in Q1 2026, selling an estimated $23.4K and leaving 363 shares worth $5.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1134.

Caitong International Asset Management first reported a position in MESO in Q1 2025 and has held it in 4 quarters since. The position peaked at $31.9K in Q4 2025. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Caitong International Asset Management held 363 shares of Mesoblast worth $5.58K as of Q1 2026.
  • Caitong International Asset Management sold 1,403 Mesoblast shares in Q1 2026, an estimated $23.4K.
  • Mesoblast made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1134 holding.
  • Caitong International Asset Management first reported a position in Mesoblast in Q1 2025 and has held it in 4 quarters since.
  • Caitong International Asset Management's Mesoblast position peaked at $31.9K in Q4 2025.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.